Research Article
Site-Specific Analysis of Inflammatory Markers in Discoid Lupus Erythematosus Skin
Table 1
DLE patient characteristics.
| | Patient no. | SLE (Y/N) | Age | Gender | Ethnicity | No. of SLE Criteria | Treatment at biopsy | Biopsy site |
| | 1 | N | 55 | F | Caucasian | 3 | — | Shoulder | | 2 | N | 52 | F | Caucasian | 3 | HCQ | Scalp | | 3 | N | 46 | F | Caucasian | 3 | — | Scalp | | 4 | N | 41 | F | AA | 1 | — | Scalp | | 5 | N | 50 | F | AA | 2 | — | Chin | | 6 | N | 42 | F | Caucasian | 1 | — | Cheek | | 7 | N | 47 | M | AA | 2 | — | Scalp | | 8 | N | 31 | F | AA | 1 | — | Scalp | | 9 | N | 36 | F | AA | 3 | — | Scalp | | 10 | N | 62 | F | Caucasian | 3 | — | Cheek | | 11 | N | 45 | F | Caucasian | 2 | — | Nasal Ala | | 12 | N | 41 | F | AA | 3 | — | Scalp | | 13 | N | 50 | M | AA | 2 | — | Scalp | | 14 | Y | 51 | F | Asian | 5 | HCQ, MM, prednisone | Scalp | | 15 | Y | 42 | F | Hispanic | 6 | Prednisone | Arm | | 16 | Y | 31 | F | AA | 9 | MM, prednisone, quinacrine | Upper thigh | | 17 | Y | 39 | F | AA | 5 | HCQ, prednisone | Scalp | | 18 | Y | 73 | F | Caucasian | 7 | Prednisone | Cheek | | 19 | Y | 54 | F | AA | 5 | HCQ | Shoulder | | 20 | Y | 54 | F | AA | 4 | — | Scalp | | 21 | Y | 36 | F | AA | 5 | Prednisone | Scalp | | 22 | Y | 42 | F | AA | 6 | — | Scalp | | 23 | Y | 50 | F | AA | 5 | — | Shoulder |
|
|
Abbreviations: AA: African American, DLE: discoid lupus erythematosus, HCQ: hydroxychloroquine, MM: mycophenolate mofetil, SLE: systemic lupus erythematosus.
|
